Immune tolerance from gene expression to drug discovery l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 34

Immune Tolerance: from Gene Expression to Drug Discovery PowerPoint PPT Presentation


  • 125 Views
  • Uploaded on
  • Presentation posted in: General

Immune Tolerance: from Gene Expression to Drug Discovery. Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale). Immune Tolerance and Therapy. Therapy to reverse breakdown of self tolerance in autoimmune diseases

Download Presentation

Immune Tolerance: from Gene Expression to Drug Discovery

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Immune tolerance from gene expression to drug discovery l.jpg

Immune Tolerance: from Gene Expression to Drug Discovery

Therapeutic Immunology Group

(Prof. H. Waldmann)

Therapeutic Antibody Centre

(Prof. G. Hale)


Immune tolerance and therapy l.jpg

Immune Tolerance and Therapy

  • Therapy to reverse breakdown of self tolerance in autoimmune diseases

  • Tolerance induction rather than non-specific immunosuppression to avoid rejection of transplanted organs

  • Reversal of acquired tolerance to tumour antigens and latent viral infections


Slide3 l.jpg

Why Start from Gene Expression?

What are the approaches to find new therapeutics:

Random screening of chemical libraries in a “surrogate assay” (eg. suppression of antigen specific proliferation in vitro).

Look for monoclonal antibodies that modulate a function (eg. same assay).

Targeted chemical design/antibodies against specific protein structures.

But:

How to identify the most relevant/specific target proteins on possibly rare cells? Ideally we want targets expressed ONLY on target cells to avoid potential toxicity against other tissues.

An answer:

Look for genes that are specifically expressed in the functional cell type of interest – in our example, Th1 but NOT T regulatory (Treg) cells.


Slide4 l.jpg

Methods for Analysing Gene Expression

Analysis of known genes (RT-PCR/Antibodies/Protein Gels):

There are >1000 interesting “immunological” genes and probably many more important but unidentified genes. How to choose?

Differential Display and Gene Cloning:

Clones genes over-expressed in one cell compared to one other, but these may be shared with other cells and you don’t know what you are working with until you have it cloned and sequenced. How to choose?

Gene Chips/Arrays

Can identify patterns of expression from many (10,000+) genes and multiple samples. Genes must already have been cloned (<1/3 of genome?), it is quick, but not very sensitive (or reliable?), and currently expensive.

SAGE (Serial Analysis of Gene Expression)

Can identify almost the entire pattern of gene expression (the “transcriptome”) with no a priori knowledge of the gene sequences. Multiple samples are directly comparable as a database. Sensitivity depends on the number of tags sequenced: this can be labour intensive.


Slide6 l.jpg

CD4+ T cell clones/lines against DBY-Ek male antigen

CloneSourcePolarised in TypeCytokines

R2.2A1(M)xRAG-1-/- IL-2 Th1IFN-g

(graft primed)

R2.4A1(M)xRAG-1-/- IL-4 Th2IL-4, IL-10

(graft primed)

Tr1D1 A1(M)xRAG-1-/- IL-10 Tr1/TregIL-10 (IL-4)

(naïve) (aCD3 cloned)

A1MPA1(M) naïve Anti-CTLA4 TregIL-10 (IL-4)

DBY-Ek peptide

SKAA1(M) + maleDBY-Ek peptide Tskin/TregIL-10

lineskin graft CD4+

sorted IELs


Slide8 l.jpg

SAGE details

AE = Nla-III

TE = BsmF1


Slide10 l.jpg

Automated DNA Sequencing Machine


Slide12 l.jpg

Analysis of SAGE data

  • Use SAGEv3.01 software (Velculescu et al) to extract numbers of tags from raw sequence files.

  • Use Access to link tags to known genes, Unigene clusters, and ESTs (from NCBI “reliable tag” list).

  • Use Excel to manipulate data tables and calculate statistics (custom written function for Beysian stats).

  • Use custom written cluster analysis and presentation program (running on Acorn RISC-PC).


Slide13 l.jpg

DC cluster

T cell clone cluster

Spleen CD4 cell cluster


Slide14 l.jpg

Clustered Expression Chart of approx. 300 known genes (CD antigens, cytokines and receptors)


Slide15 l.jpg

A close up of a Treg

cluster of known genes


Slide20 l.jpg

Real Time PCR Machine


Slide21 l.jpg

TM4

HPRT

TM4

HPRT

Th1

Th1

Treg

Treg


Slide22 l.jpg

Quantitative RT-PCR from rejecting, syngeneic and tolerant skin grafts

Ratio of tolerant to rejecting skin graft expression


Slide25 l.jpg

Fluorescence Activated Cell Scanner


Slide26 l.jpg

Th2

Th1

Tr1D1

A1MP

Tskin

Chandra/Ly116 ->

Live cells

(7AAD neg)

Permeabilized

Chandra/Ly116 ->

CD25-

Peptide

inhibition

CD4+CD25+

Chandra/Ly116 ->


Slide27 l.jpg

CD25 ->

CD103 ->

Chandra/Ly116 ->

CD4 ->

Th2 (R2.4)

Th1 (R2.2)

CD103 ->

CD103 ->

Tskin(SkA)

Treg(Tr1D1)

CD103 ->

CD103 ->


Slide28 l.jpg

The Therapeutic Antibody Centre


Slide29 l.jpg

Humanized monoclonal antibodies against cell surface molecules

expressed by effector but not regulatory T cells


Slide30 l.jpg

Monoclonal

Antibody

Production

Bioreactor

Schematic


Slide31 l.jpg

Hollow Fibre Bioreactor for Antibody Production


Slide32 l.jpg

Therapeutic antibody purification


Slide33 l.jpg

Clinical Trials of Therapeutic Antibody


Slide34 l.jpg

For more information see the TIG Web site:

www.molbiol.ox.ac.uk/pathology/tig/

Or go to the Pathology Web site:

www.path.ox.ac.uk

And click on “Herman Waldmann”


  • Login